SlideShare a Scribd company logo
1 of 2
Challenges and opportunities for community testing centres: 
TOWARDS A NETWORK OF CENTRES 
Agenda 
1 
10:00 – 10:30, Introductions 
• how this event came about 
• who is here 
• overview of agenda and aims/expected outcomes for the day 
NOTE: The following two panels will each feature three community testing sites as a 
way to get discussion started. Panellists will focus on their successes and their 
challenges in general and as well as on a specific topic. The subsequent discussion 
will allow for participants from other community testing sites to share their 
experience and also to explore specific issues in more depth, e.g., home/self-testing, 
and testing frequency; prevention and PreP; community research and how this affects 
service development; regulatory barriers and how they are circumvented/addressed; 
outcome evaluation; comprehensive sexual health services; and reaching key 
affected populations. 
10:30 – 11:30, Panel 1: Narratives from newer testing centres 
• Italy: Sandro Mattioli will introduce the Bologna centre, and then explore barriers 
community testing, mainly health authority bureaucracy, stigma, and lack of reliable 
data. He will also share how they are trying to deal with these barriers. 
• Zagreb: Zoran Dominkovic will report from Zagreb with specific reference to 
understanding why Croatian gay men don't test for HIV, or more scientifically, 
barriers for HIV testing among MSM in Croatia and what is being done to overcome 
the barriers 
• Greece: Sophocles Chanos will introduce ATH Checkpoint and explore the issue of 
how community testing sites deal with government and medical regulations relative to 
offering testing, e.g., who, where, etc. 
11:30 – 11:50, BREAK 
11:50 – 13:00, Panel 2: Narratives from older testing centres 
• Portugal: Maria José Campos will discuss CheckpointLX, especially about the need 
for implementing anonymous contact tracing 
• Barcelona: Michael Meulbroek from BCN Checkpoint will discuss their experience 
and what might be their next steps. 
• London: David Stuart and Jake Jenkins from Dean Street, with special focus on 
ChemSex, and (beyond ChemSex trends), community engagement/outreach and low 
threshold access to testing/treatment
13:00 – 14:00, LUNCH 
14:00 – 14:15, QUICK brainstorm: Reflections on the morning sessions 
2 
• key learnings 
• key challenges and threats 
14:15 – 15:30, THREE Small groups – Principles of good practice in community 
testing 
The afternoon process aims at consensus building. Participants first work in small 
groups to pull together their experience as well as what they have learned by developing 
together a set of principles/recommendations about what is likely to promote good practice in 
community testing. 
15:30 – 15:50, BREAK 
15:50 – 16:30, Towards consensus on good practice in community testing 
The previous small group discussions will then be shared in plenary where key 
common themes will be identified. The aim is to produce an outcome document of these 
principles for circulation soon after the workshop 
16:30 – 17:00, Conclusions 
• next steps 
• participant comments on day 
Supported by generous grants from Gilead Sciences, Janssen Pharmaceuticals and 
ViiV Healthcare and administered by International HIV Partnerships (IHP). 
Special thanks to the steering committee members from 56 Dean Street, ATH 
Checkpoint, BCN Checkpoint, Checkpoint LX, and IHP; Bryan Teixeira, chair, and 
Sylvie Beaumont, rapporteur; the administration team; and HIV in Europe.

More Related Content

More from ReShape

Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1ReShape
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeReShape
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckReShape
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...ReShape
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersReShape
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...ReShape
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganReShape
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum ReportReShape
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and InjectingReShape
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheetReShape
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenonReShape
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...ReShape
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy responseReShape
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapyReShape
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsReShape
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveReShape
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze ReShape
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSexReShape
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardReShape
 

More from ReShape (20)

Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum Report
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and Injecting
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheet
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenon
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...
 
ChemSex
ChemSexChemSex
ChemSex
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy response
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapy
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions Considerations
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK Perspective
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSex
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forward
 

Recently uploaded

Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxAntiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxdrdeepikaj
 
Valle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseValle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseKristin Hetzer
 
Best Erectile Dysfunction Treatment In Narela
Best Erectile Dysfunction Treatment In NarelaBest Erectile Dysfunction Treatment In Narela
Best Erectile Dysfunction Treatment In NarelaLalClinic
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\DanielOliver74
 
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfVirtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfsmartcare
 
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)Chris Shade
 
Benefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptxBenefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptxDentulu Inc
 
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdfRobert Cole
 
Leaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptomsLeaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptomswajidullah9551
 
Ovarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptxOvarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptxovidiubedreag
 
Mental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck PresentationMental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck PresentationStartupSprouts.in
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxBlake100757
 
Breaking Down Oppositional Defiant Disorder Treatments
Breaking Down Oppositional Defiant Disorder TreatmentsBreaking Down Oppositional Defiant Disorder Treatments
Breaking Down Oppositional Defiant Disorder TreatmentsOppositional Defiant Disorder
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxSachin Mittal
 
Management of Colorectal Cancer for the Trainee Surgeon
Management of Colorectal Cancer for the Trainee SurgeonManagement of Colorectal Cancer for the Trainee Surgeon
Management of Colorectal Cancer for the Trainee SurgeonMinistry of Health, Sri Lanka
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfSachin Sharma
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaGaurav Gangwani
 
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...saimasadaf14
 

Recently uploaded (20)

Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxAntiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
 
Valle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseValle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder Abuse
 
Best Erectile Dysfunction Treatment In Narela
Best Erectile Dysfunction Treatment In NarelaBest Erectile Dysfunction Treatment In Narela
Best Erectile Dysfunction Treatment In Narela
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
 
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfVirtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
 
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
 
Benefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptxBenefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptx
 
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
 
Emergency Rooms in Lucknow | Apollo ICU ER
Emergency Rooms in Lucknow | Apollo ICU EREmergency Rooms in Lucknow | Apollo ICU ER
Emergency Rooms in Lucknow | Apollo ICU ER
 
Leaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptomsLeaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptoms
 
Ovarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptxOvarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptx
 
Mental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck PresentationMental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck Presentation
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
Importance-of-Protein-During-Pregnancy Time
Importance-of-Protein-During-Pregnancy TimeImportance-of-Protein-During-Pregnancy Time
Importance-of-Protein-During-Pregnancy Time
 
Breaking Down Oppositional Defiant Disorder Treatments
Breaking Down Oppositional Defiant Disorder TreatmentsBreaking Down Oppositional Defiant Disorder Treatments
Breaking Down Oppositional Defiant Disorder Treatments
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docx
 
Management of Colorectal Cancer for the Trainee Surgeon
Management of Colorectal Cancer for the Trainee SurgeonManagement of Colorectal Cancer for the Trainee Surgeon
Management of Colorectal Cancer for the Trainee Surgeon
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
 
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
 

Challenges and opportunities for community testing centres: Towards a network of centres - Agenda

  • 1. Challenges and opportunities for community testing centres: TOWARDS A NETWORK OF CENTRES Agenda 1 10:00 – 10:30, Introductions • how this event came about • who is here • overview of agenda and aims/expected outcomes for the day NOTE: The following two panels will each feature three community testing sites as a way to get discussion started. Panellists will focus on their successes and their challenges in general and as well as on a specific topic. The subsequent discussion will allow for participants from other community testing sites to share their experience and also to explore specific issues in more depth, e.g., home/self-testing, and testing frequency; prevention and PreP; community research and how this affects service development; regulatory barriers and how they are circumvented/addressed; outcome evaluation; comprehensive sexual health services; and reaching key affected populations. 10:30 – 11:30, Panel 1: Narratives from newer testing centres • Italy: Sandro Mattioli will introduce the Bologna centre, and then explore barriers community testing, mainly health authority bureaucracy, stigma, and lack of reliable data. He will also share how they are trying to deal with these barriers. • Zagreb: Zoran Dominkovic will report from Zagreb with specific reference to understanding why Croatian gay men don't test for HIV, or more scientifically, barriers for HIV testing among MSM in Croatia and what is being done to overcome the barriers • Greece: Sophocles Chanos will introduce ATH Checkpoint and explore the issue of how community testing sites deal with government and medical regulations relative to offering testing, e.g., who, where, etc. 11:30 – 11:50, BREAK 11:50 – 13:00, Panel 2: Narratives from older testing centres • Portugal: Maria José Campos will discuss CheckpointLX, especially about the need for implementing anonymous contact tracing • Barcelona: Michael Meulbroek from BCN Checkpoint will discuss their experience and what might be their next steps. • London: David Stuart and Jake Jenkins from Dean Street, with special focus on ChemSex, and (beyond ChemSex trends), community engagement/outreach and low threshold access to testing/treatment
  • 2. 13:00 – 14:00, LUNCH 14:00 – 14:15, QUICK brainstorm: Reflections on the morning sessions 2 • key learnings • key challenges and threats 14:15 – 15:30, THREE Small groups – Principles of good practice in community testing The afternoon process aims at consensus building. Participants first work in small groups to pull together their experience as well as what they have learned by developing together a set of principles/recommendations about what is likely to promote good practice in community testing. 15:30 – 15:50, BREAK 15:50 – 16:30, Towards consensus on good practice in community testing The previous small group discussions will then be shared in plenary where key common themes will be identified. The aim is to produce an outcome document of these principles for circulation soon after the workshop 16:30 – 17:00, Conclusions • next steps • participant comments on day Supported by generous grants from Gilead Sciences, Janssen Pharmaceuticals and ViiV Healthcare and administered by International HIV Partnerships (IHP). Special thanks to the steering committee members from 56 Dean Street, ATH Checkpoint, BCN Checkpoint, Checkpoint LX, and IHP; Bryan Teixeira, chair, and Sylvie Beaumont, rapporteur; the administration team; and HIV in Europe.